MetaCap

Boston Scientific Earnings

NYSE: BSXHealth CareMedical/Dental InstrumentsUSD

42.22+0.175 (+0.42%)

Market open · Delayed 15 min · as of Oct 9, 1:15 PM ET

Next earnings date

Wed, Oct 28, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$0.76

Boston Scientific earnings summary

Boston Scientific is scheduled to report Sep/2026 earnings on Oct 28, 2026 before the market opens, with analysts expecting EPS of $0.76. In its most recent report on Aug 3, 2026 (Q2 2026), BSX posted EPS of $0.61. Revenue for the quarter was $5.44 billion.

Quarterly EPS is up 15.1% from the same quarter a year earlier. Across the last 16 reports, BSX shares moved an average of 2.5% (in either direction) in the first trading session after results, rising 11 times and falling 5 times.

Summary generated from market data by MetaCap's automated system. Methodology

BSX earnings history

Boston Scientific reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 3, 2026—$0.61—+5.1%
May 1, 2026—$0.90—-4.5%
Feb 17, 2026—$0.45—+3.0%
Nov 3, 2025—$0.51—+2.7%
Aug 1, 2025—$0.53—-2.2%
May 1, 2025—$0.45—-2.0%
Feb 18, 2025—$0.38—-0.7%
Nov 1, 2024—$0.32—+5.5%
Aug 1, 2024—$0.22—+2.3%
May 1, 2024—$0.33—+1.2%
Feb 20, 2024—$0.34—+0.2%
Nov 1, 2023—$0.34—-1.8%
Aug 3, 2023—$0.18—+0.6%
May 4, 2023—$0.21—+3.5%
Feb 23, 2023—$0.09—+1.7%
Nov 3, 2022—$0.12—+2.2%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related